Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-055510
Filing Date
2026-05-13
Accepted
2026-05-13 09:27:03
Documents
2
Period of Report
2026-05-13

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0290540-6k_polyrizon.htm 6-K 16831
2 PRESS RELEASE TITLED: "POLYRIZON ADVANCES TOWARDS HUMAN CLINICAL TRIALS: SECURES ea029054002ex99-1.htm EX-99.1 12960
  Complete submission text file 0001213900-26-055510.txt   30922
Mailing Address HAPNINA ST 8 RA'ANANA Israel 4321545
Business Address HAPNINA ST 8 RA'ANANA Israel 4321545 972-54-7979668
Polyrizon Ltd. (Filer) CIK: 0001893645 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42375 | Film No.: 26971319
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)